http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2193898-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_987e69b5a2809ab8caeadab2d6dd2859
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
filingDate 2001-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2002-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_410f2b93afd541c6c73e4c299068543d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcc9623a169c55b24738a4c436d4c4f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6aecf6136c61cde8813dd951618785f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4e1b69ac523c6d66ff14b5460275796
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ecc1244f63fa0704d5346b82a268d77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e91391a82bc8c58ed50ce761242a851d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_094b55c72e11d5212d53f0b645ba33f3
publicationDate 2002-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2193898-C1
titleOfInvention Method for supervision during the first half of induced pregnancy
abstract FIELD: medicine, obstetrics. SUBSTANCE: patients with uterine hypertonicity are suggested to undergo percutaneous electroneurostimulation at 60 Hz frequency, 0.6 ms impulse duration beginning since the 5-6th wk of pregnancy at intensivity to feel pleasant pain-free vibration once-twice daily at 2-3-h-long interval per 25-30 min at 5-6 procedures daily. It is, also, suggested to detect the value of thrombotic potential index and soluble complexes of fibrin monomers and at the increase of thrombotic potential index above 15 c. u. and/or appearance of positive value of soluble complexes of fibrin monomers it is necessary to conduct 3 seances of interrupted plasmapheresis at withdrawal of 30-50% volume of circulating plasma and plasma-substitution at the ratio to withdrawn plasma volume being 1.5 : 1 at 2-3- fold successive repetition of said procedures during pregnancy course. EFFECT: higher efficiency of supervision. 3 ex
priorityDate 2001-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID235905
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1712095
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID66000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4740
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134688829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479655
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP18291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966231
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452647622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491578
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702161
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID66000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3609
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50225
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415727061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407866699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499609
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9051

Total number of triples: 44.